Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.46 |
| ▸ | MAPT | P10636 | 4/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | NSD2 | O96028 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.46 |
| ▸ | RECQL | P46063 | 2/20 | 0.46 |
| ▸ | P2RY1 | P47900 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.40 |
| ▸ | P2RY2 | P41231 | 5/20 | 0.39 |
| ▸ | MET | P08581 | 3/20 | 0.39 |
| ▸ | P2RY12 | Q9H244 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30887179 | 1.00 | MEN1 (0.46) | MEN1MAPTKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL11932628 | 0.96 | MAPT (0.43) | MEN1MAPTKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL8947711 | 0.87 | MAPK1 (0.46) | MEN1MAPTKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL341554 | 0.86 | P2RY1 (0.55) | MEN1MAPTKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL29356228 | 0.86 | P2RY1 (0.55) | MEN1MAPTKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL15452097 | 0.85 | CXCR2 (0.46) | MEN1MAPTKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL13316757 | 0.83 | MAPT (0.48) | MEN1MAPTKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL15448839 | 0.83 | SMN1; SMN2 (0.44) | MEN1MAPTKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL20043780 | 0.83 | MAPK1 (0.42) | MEN1MAPTKMT2ASMN1; SMN2ALDH1A1 | |
| SCHEMBL25851919 | 0.83 | MAPK1 (0.53) | MEN1MAPTKMT2ASMN1; SMN2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020017934-A1 | COLORED CURABLE RESIN COMPOSITION, COLOR FILTER, AND DISPLAY APPARATUS | 동우 화인켐 주식회사 | 2020-01-23 | — | — | WO | disclosed |
| EP-2480610-B1 | MIGRATION-FREE COLOURED COPOLYCONDENSATES FOR COLOURING POLYMERS | BASF SE (DE) | 2017-11-29 | — | — | EP | disclosed |
| US-20160355684-A1 | ANTHRAQUINONE DYE USED FOR A COLOR FILTER OF A LCD | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-12-08 | — | — | US | disclosed |
| US-20160355684-A1 | ANTHRAQUINONE DYE USED FOR A COLOR FILTER OF A LCD | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-12-08 | — | — | US | disclosed |
| US-6426416-B1 | TEXTILE FIBER DYES | MILLIKAN & COMPANAY | 2002-07-30 | — | — | US | disclosed |
| US-6022944-A | Anthraquinone and condensed anthraquinone colorants having sulfonamide linked poly(oxyalkylene) moieties and their preparation | MILLIKEN & COMPANY (US) | 2000-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160355684-A1 | ANTHRAQUINONE DYE USED FOR A COLOR FILTER OF A LCD | ANTXR2, AAAS, ALAD | MEN1 4333/4885MAPT 2645/4885KMT2A 1501/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.